0001437749-23-035158.txt : 20231221
0001437749-23-035158.hdr.sgml : 20231221
20231221194441
ACCESSION NUMBER: 0001437749-23-035158
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231219
FILED AS OF DATE: 20231221
DATE AS OF CHANGE: 20231221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kamke Trent G
CENTRAL INDEX KEY: 0001365739
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33092
FILM NUMBER: 231506857
MAIL ADDRESS:
STREET 1: 61 WILLOWDEAN AVENUE
CITY: WEST ROXBURY
STATE: MA
ZIP: 02132
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC
CENTRAL INDEX KEY: 0001158895
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 781-221-2266
MAIL ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-12-19
0001158895
LEMAITRE VASCULAR INC
LMAT
0001365739
Kamke Trent G
C/O LEMAITRE VASCULAR , INC.
63 SECOND AVENUE
BURLINGTON
MA
01803
1
Senior V. P., Operations
0
Common Stock
2023-12-19
4
M
0
9
0
A
8122
D
Common Stock
2023-12-19
4
F
0
79
56.06
D
8043
D
Common Stock
2023-12-19
4
M
0
1
0
A
8044
D
Common Stock
2023-12-20
4
M
0
2
0
A
8046
D
Common Stock
2023-12-20
4
F
0
49
54.85
D
7997
D
Dividend Equivalent Rights
2023-12-19
4
M
0
9
0
D
Common Stock
9
0
D
Dividend Equivalent Rights
2023-12-19
4
M
0
1
0
D
Common Stock
1
0
D
Dividend Equivalent Rights
2023-12-20
4
M
0
2
0
D
Common Stock
2
8.6411
D
Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
Represents shares acquired from the release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 20, 2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
/s/ David. Hissong
2023-12-21